ABSTRACT
INTRODUCTION
In October 1977, World Health Organisation (WHO) produced the first Model List of Essential Drugs and in 1978, the Declaration of Alma Ata identified -provision of essential drugs‖ as one of the eight elements of primary health care. WHO defined -The Essential medicines are those that satisfy the priority health care needs of the population‖. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost-effectiveness. Essential medicines are intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality and adequate information, and at a price the individual and the community can afford.‖ The implementation of the concept of essential medicines is intended to be flexible and adaptable to many different situations and it should be updated regularly 1 .
In India, there were more than 70,000 drug formulations available in the market and most of them are unnecessary, hazardous and marginal remedies. The irrational drug use is directly related to the number of brands available in the market and their promotion. 
METHODOLOGY
Our study is a comparative analytical study. By selecting the published list of NLEM 2011 and EML 2011-12 of Tamil Nadu and Kerala which were downloaded from their official websites through the sources such as The Central Drugs Standard Control Organization, KMSCL and TNMSCL. The lists were assessed and evaluated and checked for the compliance with WHO Model List of Essential Medicines. Published articles and literatures in various scientific and professional publications were reviewed based on the aims and objectives of the study. The primary purpose of NLEM is to promote rational use of medicines considering the three important aspects i.e. cost, safety and efficacy. Furthermore it promotes prescription by generic names. Comparison was made between the 17th edition of TN-EML and 4 th Edition of Kerala-EML
RESULTS & DISCUSSION.
It is observed that the total number of drugs present in the National List of Essential Medicines (NLEM), TamilNadu Essential Drug List (TN EML), Kerala Essential Drug List (KL EML) are 348 ,260, 287 drugs respectively. One hundred and sixteen drugs were found to be common in three lists. Number of drugs that are not present in TN EML and KL EML when compare with NLEM are 158 drugs.
The three lists were compared with the WHO model list 6 and observed that WHO list contains 362Medicine out of that 124 medicines were not present in NLEMI, Tamil Nadu EML and Kerala EML. Tamil Nadu and Kerala finalize their EML every year, where as NLEMI was revised only two times. Criteria for modifying the NLEMI was done through experts from different disciplines, from medical and pharmaceutical institutes and hospitals, from across the country and states specifically gave the reasons or evidence which guided their decision regarding addition/deletion/alteration. . However, the TNMSC could not or rather it did not try to convert the essential drug list in the form of a scientific Hospital or State Formulary. But development of handbook for pharmacists and regular publication of newsletter for healthcare professionals helped promoting the concept of rational drug use. The TNMSC entrusted the responsibility of publication of the hand book for pharmacists to a private pharmacy college in the state and the authors have written it in a professional manner.
The KMSCL finalizes the EDL every year. The first EDL was published in 2008 containing 527 items of medicines, sutures, surgical and other hospital items including detergents and chemicals. The number of drugs presented in each category was shown in Figure 1 . The annual indents are prepared by the DHS and DME and the Corporation does the tender process based on the estimated requirements. However during the first three years, the KMSCL could not give much concentration and care activities like publication of EDL in booklet form every year and make it available to all health care centers as done by TNMSC. The KMSCL is yet to take up issues like publication of Anti anemic drugs present in TN EML and NLEMI is Cyanocobalamin, where as in KL EML both Cyanocobalamin and Mecobalamin were present. According to Fred Bloem, after injection of Cyanocobalamin it will convert to methylcobalamin and then hydroxocobalamin to be used by the body. Due to the toxins and heavy metals present in the liver of smokers, these people are less able to transform Cyanocobalamin into methocobalamin. Were as, Hydroxocobalamin is the most bioactive form of vitamin B 12 ; it retained longer in the body and can be dosed less frequently. But the cost of hydroxocobalamin and Mecobalamin were very much higher than cyanocobalamin. In WHO EML they have included hydroxocobalamin 11 .
Selection Criteria
The selection of essential drugs for health care delivery system can be done in a two -step process: First: Development of Standard treatment Guidelines for common diseases and complaints, Second: Identification of drug and drug products, which provide most cost effective therapy.
WHO recommends the following criteria for consideration on selection of essential drugs or medicines 12
1.
Only medicines for which sound and adequate evidence of efficacy and safety in a variety of settings is available be selected. 2. Relative cost effectiveness is a major consideration for choosing medicines within the same therapeutic category. In comparisons between, the total costs of the treatment not only the unit cost of the medicine must be considered and be compared with its efficacy. 3. The accessibility of facilities for manufacture and storage. 4. Adequate quality, ensured bioavailability and stability preserved medicine must be available. 5. Ideally the essential medicines should be formulated as single compounds. Fixed dose combination products are selected only when the combination has a proven advantage in therapeutic effect, safety and adherence or in decreasing the emergence of drug resistance in malaria, tuberculosis and HIV/AIDS.
The selection of medicines for use within the state or country's public hospitals is a critical process.
Ideally the selection of medicines should be linked to evidence based standard clinical guidelines and the list may be divided into levels of care and that both are regularly reviewed and updated 12 .
The following approach may be useful. From the study it reveals that improper selection of essential medicines from the same category is unnecessary, here in KL EML they included Ranitidine, Omeprazole, Rabeprazole, and Pantaprazole. Considering NLEMI they have selected Ranitidine, Famotidine, Omeprazole and Pantaprazole for Gastrointestinal medicines 10 .While TN EML had selected Omeprazole and Ranitidine appropriately.
Zinc Sulphate formulation used for the treatment of pediatric diarrhoea was included in NLEMI , but both TN EML and KL EML fail to include this medicine in list. Zinc tablets were available in TN EML under the vitamins and minerals section. Even though zinc sulphate were supplied to all sub centres through National Rural Health Mission (NRHM) 10 .
Child friendly dosage forms were available in TN EML for Anti Infective and Vitamin and mineral Sections. Even though it is not specifically mentioned, Pediatric formulations were available in KL EML. Considering NLEMI many drugs have formulations to go with different adult doses. For example, fluconazole tablets are presented in four different strengths (50 mg, 100 mg, 150 mg and 200 mg) for adults in the list. But there is no dose / dosage form for Children 10 .
Comparing the three lists, TN EML has less number of medicines compared to other two. TNMSC had the system of distributing 10 percent of the annual budget to hospitals which has helped the Corporation to counter the criticism that the drug list was inadequate 13 .
CONCLUSION
The EML can help countries to rationalize the purchasing and distribution of medicines, by this means reducing costs to the health system .The KL-EML have more number of medicines when compared to TN-EML, In KL-EML medicines was not classified according to its therapeutic categories as done by TN-EML and NEMLI. But the recent edition of KL EML, categories medicine and brings it like a booklet form. The common therapeutic categories include most of the drugs in all the 3 lists when compare with WHO model list.
For the publication and popularisation of EML the printed copies of EML was made available at all government level and to individual clinicians and other health care providers to make them aware and adhere to in discharging their duties. Criteria for modifying EML of two states was done through a committee of experts from various disciplines, they gave the reasons or evidence which steer their decision regarding addition/deletion/alteration. There is a need for certain add-on drugs like antidotes, Zinc Sulphate for pediatric diarrhoea in TN EML and KL EML. It was found that the KL EML was not supported by STG and there is redundant exclusion of child friendly dosage forms in NLEMI.
